Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-12-07

Clinical Trial Update: Phase 2 Randomized Clinical Trial of Luminate® as Compared to Avastin® in the Treatment of Diabetic Macular Edema [Phase 2]

View source ↗

Summary

A Phase 2 randomized trial comparing Luminate to Avastin for diabetic macular edema has completed recruitment with results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Avastin (bevacizumab)
  • Luminate

Snippet

Sponsor: Allegro Ophthalmics, LLC | Conditions: Diabetic Macular Edema | Phase 2 | Status: COMPLETED | Results posted: 2018-12-07